Dr. Robert Allen Vescio MD Hematologist

Dr. Robert Vescio is a hematologist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Cedars-Sinai Medical Center and Ronald Reagan University of California Los Angeles Medical Center. He received his medical degree from UC San Diego School of Medicine and has been in practice for 28 years. He is one of 36 doctors at Cedars-Sinai Medical Center and one of 59 at Ronald Reagan University of California Los Angeles Medical Center who specialize in Hematology.

Are you Dr. Vescio? Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

Cedars-Sinai Medical Center
Ranked #41 in Cancer

Ronald Reagan University of California Los Angeles Medical Center
Ranked #9 in Cancer

Education & Medical Training

University of California at San Diego
Residency, Internal Medicine, 1986–1989

UCLA Medical Center
Fellowship, Hematology, 1990–1993

UC San Diego School of Medicine
Class of 1986

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Hematology

American Board of Internal Medicine
Certified in Medical Oncology

CA State Medical License
Active through 2015

Awards, Honors & Recognition

Super Doctor, SuperDoctors.com

Whos Who in Medicine and Healthcare, Marquis Whos Who

Publications & Presentations

A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.
Berenson, J. R.,Hilger, J. D.,Yellin, O.,Boccia, R. V.,Matous, J.,Dressler, K.,Ghazal, H. H.,Jamshed, S.,Kingsley, E. C.,Harb, W. A.,Noga, S. J.,Nassir, Y.,Swift, R. A.,Vescio, R.

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study.
Reece, D. E., Hegenbart, U., Sanchorawala, V., Merlini, G., Palladini, G., Bladé, J., Fermand, J. P., Hassoun, H., Heffner, L., Vescio, R. A., Liu, K., Enny, C., Esseltine, D. L., van de Velde, H., Cakana, A., Comenzo, R. L.

Phase I/II trial assessing bortezomib and melphalan combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Berenson, J.R., Yang, H.H., Sadler, K., Jarutirasarn, S.G., Vescio, R.A., Mapes, R., Purner, M., Lee, S., Wilson, J., Morrison, B., Adams, J., Schenkein, D., Swift, R.

See all 74 publications

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Hematologists

See all Hematologists near Los Angeles, CA See all Hematologists in California

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.